Healthpeak Properties (DOC) Projected to Post Quarterly Earnings on Thursday

Healthpeak Properties (NYSE:DOC - Get Free Report) is expected to post its Q2 2025 quarterly earnings results after the market closes on Thursday, July 24th. Analysts expect Healthpeak Properties to post earnings of $0.46 per share and revenue of $697.14 million for the quarter. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The business's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.45 EPS. On average, analysts expect Healthpeak Properties to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Healthpeak Properties Price Performance

NYSE DOC traded up $0.07 during trading hours on Friday, reaching $18.33. The company's stock had a trading volume of 4,445,131 shares, compared to its average volume of 5,364,250. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35. The company's 50-day moving average is $17.55 and its two-hundred day moving average is $18.92. Healthpeak Properties has a fifty-two week low of $16.64 and a fifty-two week high of $23.26. The stock has a market cap of $12.73 billion, a PE ratio of 45.83, a PEG ratio of 2.08 and a beta of 1.03.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Friday, September 19th will be paid a dividend of $0.1017 per share. The ex-dividend date is Friday, September 19th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.66%. Healthpeak Properties's dividend payout ratio (DPR) is 305.00%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Wedbush reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Wells Fargo & Company decreased their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Robert W. Baird cut their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Finally, Evercore ISI reduced their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $23.27.

Insiders Place Their Bets

In other news, CEO Scott M. Brinker bought 11,337 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the transaction, the chief executive officer owned 201,863 shares of the company's stock, valued at $3,568,937.84. This represents a 5.95% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Tommy G. Thompson bought 5,777 shares of Healthpeak Properties stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director directly owned 144,290 shares of the company's stock, valued at $2,491,888.30. The trade was a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 29,764 shares of company stock valued at $521,909 over the last quarter. Company insiders own 0.23% of the company's stock.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC lifted its stake in shares of Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after purchasing an additional 1,231 shares in the last quarter. Woodline Partners LP raised its holdings in Healthpeak Properties by 41.3% in the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust's stock valued at $1,195,000 after buying an additional 17,279 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust's stock valued at $2,463,000 after buying an additional 63,930 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.